Brokerages expect that AmerisourceBergen Corp. (NYSE:ABC) will announce earnings per share (EPS) of $1.43 for the current quarter, according to Zacks. Six analysts have made estimates for AmerisourceBergen’s earnings, with estimates ranging from $1.40 to $1.46. AmerisourceBergen reported earnings of $1.33 per share in the same quarter last year, which indicates a positive year over year growth rate of 7.5%. The firm is scheduled to report its next quarterly earnings report on Thursday, November 1st.

According to Zacks, analysts expect that AmerisourceBergen will report full year earnings of $6.48 per share for the current year, with EPS estimates ranging from $6.45 to $6.51. For the next fiscal year, analysts expect that the company will post earnings of $7.15 per share, with EPS estimates ranging from $6.93 to $7.29. Zacks’ earnings per share calculations are a mean average based on a survey of sell-side research firms that that provide coverage for AmerisourceBergen.

AmerisourceBergen (NYSE:ABC) last released its earnings results on Thursday, August 2nd. The company reported $1.54 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.46 by $0.08. The firm had revenue of $43.14 billion during the quarter, compared to analyst estimates of $43.05 billion. AmerisourceBergen had a net margin of 0.69% and a return on equity of 48.65%. The business’s revenue was up 11.4% on a year-over-year basis. During the same quarter last year, the business earned $1.43 EPS.

Several equities research analysts have recently issued reports on ABC shares. ValuEngine lowered shares of AmerisourceBergen from a “hold” rating to a “sell” rating in a report on Tuesday, May 22nd. Morgan Stanley lowered their target price on shares of AmerisourceBergen from $97.00 to $88.00 and set an “equal weight” rating for the company in a report on Tuesday, July 3rd. Robert W. Baird restated a “neutral” rating and issued a $94.00 target price on shares of AmerisourceBergen in a report on Friday, July 20th. Finally, Mizuho restated a “hold” rating and issued a $90.00 target price on shares of AmerisourceBergen in a report on Sunday, August 12th. Two analysts have rated the stock with a sell rating, six have given a hold rating and nine have issued a buy rating to the company. AmerisourceBergen has a consensus rating of “Hold” and an average price target of $101.80.

In related news, insider Kathy H. Gaddes sold 2,652 shares of AmerisourceBergen stock in a transaction dated Wednesday, June 20th. The shares were sold at an average price of $92.03, for a total transaction of $244,063.56. Following the completion of the sale, the insider now owns 3,891 shares in the company, valued at approximately $358,088.73. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Dale Danilewitz sold 3,120 shares of AmerisourceBergen stock in a transaction dated Monday, July 2nd. The shares were sold at an average price of $84.80, for a total transaction of $264,576.00. Following the sale, the insider now owns 3,120 shares of the company’s stock, valued at approximately $264,576. The disclosure for this sale can be found here. Insiders have sold a total of 96,587 shares of company stock valued at $8,191,700 in the last quarter. 27.30% of the stock is currently owned by company insiders.

Institutional investors and hedge funds have recently made changes to their positions in the stock. First Mercantile Trust Co. bought a new stake in AmerisourceBergen during the 2nd quarter valued at about $107,000. Centaurus Financial Inc. bought a new stake in AmerisourceBergen during the 2nd quarter valued at about $129,000. Capital Analysts LLC lifted its holdings in AmerisourceBergen by 261.1% during the 2nd quarter. Capital Analysts LLC now owns 1,531 shares of the company’s stock valued at $131,000 after buying an additional 1,107 shares in the last quarter. Piedmont Investment Advisors LLC bought a new stake in AmerisourceBergen during the 2nd quarter valued at about $157,000. Finally, K.J. Harrison & Partners Inc bought a new stake in AmerisourceBergen during the 2nd quarter valued at about $200,000. Institutional investors own 66.77% of the company’s stock.

AmerisourceBergen stock opened at $85.84 on Friday. The stock has a market capitalization of $18.44 billion, a PE ratio of 14.60, a PEG ratio of 1.33 and a beta of 1.04. The company has a debt-to-equity ratio of 1.39, a current ratio of 0.94 and a quick ratio of 0.51. AmerisourceBergen has a 12-month low of $71.90 and a 12-month high of $106.27.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 4th. Investors of record on Monday, August 20th were issued a dividend of $0.38 per share. The ex-dividend date was Friday, August 17th. This represents a $1.52 dividend on an annualized basis and a yield of 1.77%. AmerisourceBergen’s payout ratio is 25.85%.

About AmerisourceBergen

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.

Recommended Story: Should You Consider an Index Fund?

Get a free copy of the Zacks research report on AmerisourceBergen (ABC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for AmerisourceBergen (NYSE:ABC)

Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.